Device User-Fee Agreement Gets A Senate Hearing
Executive Summary
US FDA user-fee reauthorization agreements, including the medical device MDUFA IV package, will be dissected at a Senate Health, Education, Labor, and Pensions (HELP) Committee hearing on March 21.